Testing an enhanced care package for people with advanced HIV disease
Tests extra screening and preventive care in adults with advanced HIV disease.
Plain-language title generated from the registry record
Registry title: An Enhanced Package of Care to Reduce Reduce Mortality in Advanced HIV Disease
Key facts
- Where
- Kampala, UgandaSee the site
- Phase
- Phase 3
Where in Uganda
- kisugu health center IVKampala, UgandaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Makerere University
- Trial code
- NCT05085171
- Record updated
- 12 July 2022
- Original description
A community-based Phase III, cluster randomized trial that seeks to determine the 24 week survival with retention in care of point of care CD4 testing with visitect and an enhanced package of screening and prophylaxis for opportunistic infections among patients with advanced HIV disease.Read full original descriptionShow less
A Community-based Phase III, Cluster Randomized Trial of Point-of-care CD4 Testing and Enhanced Screening and Prophylaxis in Advanced HIV Disease
A community-based Phase III, cluster randomized trial that seeks to determine the 24 week survival with retention in care of point of care CD4 testing with visitect and an enhanced package of screening and prophylaxis for opportunistic infections among patients with advanced HIV disease.
Inclusion: Age >18 years; CD4<200 cells/µL; Ability and willingness to give informed consent for the enhanced package of care arm.
Exclusion: Known virologic suppression (viral load <1000 copies/mL) within prior 3 months; Cannot or unlikely to attend regular clinic visits.